Andrei Shustov
Chief Tech/Sci/R&D Officer at CELLECTAR BIOSCIENCES, INC.
Net worth: 166 212 $ as of 2024-04-29
Andrei Shustov active positions
Companies | Position | Start | End |
---|---|---|---|
CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2023-02-14 | - |
Career history of Andrei Shustov
Former positions of Andrei Shustov
Companies | Position | Start | End |
---|---|---|---|
SEAGEN INC. | Corporate Officer/Principal | - | - |
Training of Andrei Shustov
S. I. Georgievsky's Medical Academy | Doctorate Degree |
Statistics
International
United States | 3 |
Russia | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Andrei Shustov
- Experience